Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial

References

• Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997; 349:1269–1276.
   PubMed Web of Science ®Google Scholar
• Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596–601.
   PubMed Web of Science ®Google Scholar
• Bonita R, Reddy S, Galbraith S, Bettcher D, MacIntyre M, Peden M, . Neglected global epidemics: Three growing threats. Beaglehole R, Irwin A, Prentice T. The World Health Report 2003 – Shaping the Future. Geneva: World Health Organization; 2003. 83–102.
   Google Scholar
• Perkovic V, Huxley R, Wu Y, Prabhakaran PD, MacMahon S. The burden of blood pressure-related disease: A neglected priority in global health. Hypertension. 2007;50:991–997.
   PubMed Web of Science ®Google Scholar
• Sobngwi E, Mbanya JC, Unwin NC, Porcher R, Kengne AP, Fezeu L, . Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon. Intern J Epidemiol. 2004;33:769–776.
   PubMed Web of Science ®Google Scholar
• Donnison C. Blood pressure in African natives: Its bearing on the aetiology of hyperpiesa and arteriosclerosis. Lancet. 1929;i:6–7.
   Google Scholar
• Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005;112:3562–3568.
   PubMed Web of Science ®Google Scholar
• World Health Organization ISoHWG. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983–1992.
   Google Scholar
• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, . 2007 guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–1187.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black BK, Cushman WC, Green LA, Izzo JL, Jr., , and the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, . Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005; 165:1147–1152.
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, , for the ASCOT Investigators. Prevention of cardiovascular events with an amlodipine ± perindopril strategy compared with an atenolol ± thiazide strategy. The Anglo-Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet. 2005;366:895–906.
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, , for the ACCOMPLISH trial investigators. Benazapril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417–2428.
   PubMed Web of Science ®Google Scholar
• Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Management of high blood pressure in African Americans. Arch Intern Med. 2003;163:525–541.
   Google Scholar
• , Joint National Hypertension Guideline Working Group 2006Seedat YK, Croasdale MA, Milne FJ, Opie LH, Pinkney-Atkinson VJ, Rayner BL. South African Hypertension Guideline 2006. S Afr Med J. 2006;96:337–362.
   PubMed Web of Science ®Google Scholar
• Lemogoum D, Seedat YK, Mabadeje AFB, Mendis S, Bovet P, Onwubere B, Blacket KN, Lenfant C, M'Buyamba-Kabangu JR, Block P, Belhocine P, Degaute JP, on behalf of the International Forum for Hypertension control and prevention in Africa (IFHA). Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa. J Hypertens. 2003; 21:1993–2000.
   PubMed Web of Science ®Google Scholar
• Guidelines Committee. Guidelines for the Management of Hypertension in Nigeria. Enugu, Nigeria, Ezu Books Ltd; 2005.
   Google Scholar
• Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH, Jr., , on behalf of the International Society on Hypertension in Blacks. Management of hypertension in Blacks: An update of the International Society of Hypertension in Blacks Consensus Statement. Hypertension. 2010; 56:780–800.
   PubMed Web of Science ®Google Scholar
• Young JH, Chang YP, Kim JDO, Chretien JP, Klag MJ, Levine AS, . Differential susceptibility to hypertension is due to selection during the out-of Africa expansion. PLoS Genet. 2005;1:e82.
   Google Scholar
• Zhu X, Luke A, Cooper RS, Quertermous T, Hanis C, Mosley T, . Admixture mapping for hypertension loci with genome-wide markers. Nat Genet. 2005;37:177–181.
   Google Scholar
• Kaufman JS, Owoaje EE, James SA, Rotimi CN, Cooper RS. Determinants of hypertension in West Africa: Contribution of anthropometric and dietary factors to urban and socioeconomic gradients. Am J Epidemiol. 1996;143:1203–1218.
   PubMed Web of Science ®Google Scholar
• The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabet Care. 1999;22 Suppl 1:S5–S19.
   Google Scholar
• Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161–186.
   PubMed Web of Science ®Google Scholar
• Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: Validation with autopsy findings. Circulation. 1987; 75:565–572.
   PubMed Web of Science ®Google Scholar
• Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995;24:417–423.
   Google Scholar
• The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and , of the European Society of Cardiology (ESC)Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, . 2007 guidelines for the management of arterial hypertension. Eur Heart J. 2007;28:1462–1536.
   Google Scholar
• El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: The Omron M5-I and the Omron 705IT. Blood Press Monit. 2003;8:127–133.
   PubMed Web of Science ®Google Scholar
• O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, , on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697–701.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Byttebier G, Buntinx F, Celis H, O'Brien ET, Fagard R, for the Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. JAMA. 1997;278:1065–1072.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Den Hond E, Celis H, Fagard R, Keary L, Vandenhoven G, , for the Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office. A randomized controlled trial. JAMA. 2004;291:955–964.
   PubMed Web of Science ®Google Scholar
• Shiburi CP, Staessen JA, Maseko M, Wojciechowska W, Thijs L, Van Bortel LM, . Reference values for SphygmoCor measurements in South Africans of African ancestry. Am J Hypertens. 2006;19:40–46.
   PubMed Web of Science ®Google Scholar
• 41st World Medical Assembly. Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ. 1990;24:606–609.
   Google Scholar
• Staessen JA, Kuznetsova T, Zhang H, Maillard M, Bochud M, Hasenkamp S, . Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension. 2008;51:1643–1650.
   PubMed Web of Science ®Google Scholar
• Li Y, Zagato L, Kuznetsova T, Tripodi G, Zerbini G, Richart T, . Angiotensin-converting enzyme I/D and a-adducin Gly460Trp polymorphisms. From angiotensin-converting enzyme activity to cardiovascular outcome. Hypertension. 2007;49:1291–1297.
   PubMed Web of Science ®Google Scholar
• Kuznetsova T, Staessen JA, Brand E, Cwynar M, Stolarz K, Thijs L, . Context-dependency of relations between cardiovascular phenotypes and genes involved in sodium homeostasis: Findings from the European Project on Genes in Hypertension. Curr Hypertens Rev. 2006;2:275–281.
   Google Scholar
• Chuang-Stein C. Some issues concerning the normalization of laboratory data based on reference ranges. Drug Inform J. 2000;35:153–156.
   Google Scholar
• Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: A meta-analysis [erratum published in The Lancet 2002, volume 359, January 26, p 360]. Lancet. 2001;358:1305–1315.
   PubMed Web of Science ®Google Scholar
• Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet. 2003;362: 1527–1535.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: An update including the 2003-2004 secondary prevention trials. Hypertens Res. 2005; 28:385–407.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Reboldi G, Angeli A, Gattobigio R, Bentivoglio M, Thijs L, . Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension. 2005;46:386–392.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Thijs L, Fagard R, Celis H, Birkenhäger WH, Bulpitt CJ, , for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens. 2004;22:847–857.
   PubMed Web of Science ®Google Scholar
• Cooper RS, Rotimi CN, Kaufman JS, Muna WFT, Mensah GA. Hypertension treatment and control in sub-Saharan Africa: The epidemiological basis for policy. Br Med J. 1998;316:614–617.
   PubMed Web of Science ®Google Scholar
• Cooper RS, Osotimehin B, Kaufman JS, Forrester T. Disease burden in sub-Saharan Africa: What should we conclude in the absence of data? Lancet. 1998;351:208–210.
   Google Scholar
• Ukoh VA. Admission of hypertensive patients at the University of Benin Teaching Hospital, Nigeria. East Afr Med J. 2007;84:329–335.
   Google Scholar
• Ike SO. The pattern of admissions into the medical wards of the University of Nigeria Teaching Hospital, Enugu (2). Niger J Clin Pract. 2008;11:185–192.
   Web of Science ®Google Scholar
• Walker AR, Walker BF, Dunn MJ, Dunn SE. Causes of admissions of rural African patients to Murchison Hospital, Natal, South Africa. J R Soc Health. 1994;114:33–38.
   Google Scholar
• Ojji DB, Alfa J, Ajayi SO, Mamven MH, Falase AO. Pattern of heart failure in Abuja, Nigeria: An echocardiographic study. Cardiovasc J Afr. 2009;20:349–352.
   Google Scholar
• Damasceno A, Cotter G, Dzudie A, Sliwa K, Mayosi BM. Heart failure in sub-Saharan Africa: Time for action. J Am Coll Cardiol. 2007;50:1688–1693.
   PubMed Web of Science ®Google Scholar
• Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, . Predominance of heart failure in the Heart of Soweto Study cohort: Emerging challenges for urban African communities. Circulation. 2008;118:2360–2367.
   PubMed Web of Science ®Google Scholar
• Onwuchekwa AC, Onwuchekwa RC, Asekomeh EG. Stroke in young Nigerian adults. J Vasc Nurs. 2009;27:98–102.
   Google Scholar
• Mensah GA. Epidemiology of stroke and high blood pressure in Africa. Heart. 2008;94:697–705.
   PubMed Web of Science ®Google Scholar
• Damasceno A, Gomes J, Azevedo A, Carrilho C, Lobo V, Lopes H, . An epidemiological study of stroke hospitalizations in Maputo, Mozambique: A high burden of disease in a resource-poor country. Stroke. 2010;41:2463–2469.
   PubMed Web of Science ®Google Scholar
• Amidu N, Owiredu WK, Woode E, Appiah R, Quaye L, Gyasi-Sarpong CK. Sexual dysfunction among Ghanaian men presenting with various medical conditions. Reprod Biol Endocrinol. 2010;8:118.
   Google Scholar
• Matekole M, Affram K, Lee SJ, Howie AJ, Michael J, Adu D. Hypertension and end-stage renal failure in tropical Africa. J Hum Hypertens. 1993;7:443–446.
   PubMed Web of Science ®Google Scholar
• Naicker S. End-stage renal disease in sub-Saharan and South Africa. Kidney Intern. 2003;63 Suppl 83:S119–S122.
   Google Scholar
• Arodiwe EB, Ike SO, Nwokediuko SC. Case fatality among hypertension-related admissions in Enugu, Nigeria. Niger J Clin Pract. 2009;12:153–156.
   Google Scholar
• Unachukwu CN, Agomuoh DI, Alasia DD. Pattern of non-communicable diseases among medical admissions in Port Harcourt, Nigeria. Niger J Clin Pract. 2008;11:14–17.
   Google Scholar
• M'Buyamba-Kabangu JR, Biswika RT, Thijs L, Tshimanga GM, Ngalula FM, Disashi T, . In-hospital mortality among black patients admitted for hypertension-related disorders in Mbuji Mayi, Congo. Am J Hypertens. 2009;22:643–648.
   Google Scholar
• Kingue S, Dzudie A, Menanga A, Akono M, Ouankou M, Muna W. Nouveau regard sur l'insuffisance cardiaque chronique de l'adulte en Afrique à l'ère de l'échocardiographie Doppler: Expérience du service de médecine de l'Hôpital Général de Yaoundé [A new look at adult chronic heart failure in Africa in the age of Doppler echocardiography: Experience of the medicine department at Yaounde General Hosptital – in French]. Ann Cardiol Angéiol (Paris). 2005; 54:276–283.
   PubMedGoogle Scholar
• Ike SO. Prevalence of hypertension and its complications among medical admissions at the University of Nigeria Teaching Hospital, Enugu (Study 2). Nig J Med. 2009;18:68–72.
   Google Scholar
• Ogeng'o JA, Olabu BO, Kilonzi JP. Pattern of aortic aneurysms in an African country. J Thorac Cardiovasc Surg. 2010;140:797–800.
   Google Scholar
• Brown MJ, Cruickshank JM, Dominiczak AF, MacGregor GA, Poulter NR, Russell GI, . Better blood pressure control: How to combine drugs? J Hum Hypertens. 2003;17:81–86.
   PubMed Web of Science ®Google Scholar
• Brown MJ. Hypertension and ethnic group. Br Med J. 2006;332:833–836.
   PubMed Web of Science ®Google Scholar
• Khan JM, Beevers DG. Management of hypertension in ethnic minorities. Heart. 2005;91:1105–1109.
   Google Scholar
• Lewin AJ, Lueg MC, Targum S, Cardenas P. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension. Clin Cardiol. 1993;16:732–736.
   Google Scholar
• Zachariah PK, Messerli FH, Mroczek W. Low-dose bisoprolol/hydrochlorothiazide: An option in first-line antihypertensive treatment. Clin Ther. 1993;15:779–787.
   Google Scholar
• Papademetriou V, Prisant M, Neutel JM, Weir MR. Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension. Am J Cardiol. 1998; 81:1363–1365.
   Google Scholar
• Prisant LM, Neutel JM, Ferdinand K, Papademetriou V, DeQuattro V, Hall WD, . Low-dose combination therapy as first-line hypertension treatment for Blacks and Nonblacks. J Natl Med Assoc. 1999;91:40–48.
   Google Scholar
• Prisant LM, Weir MR, Papademetriou V, Weber MA, Adegbile IA, Alemayehu D, . Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment. Am Heart J. 1995;130:359–366.
   PubMed Web of Science ®Google Scholar
• Neutel JM, Rolf CN, Valentine SN, Li J, Lucas C, Marmorstein BL. Low-dose combination therapy as first line treatment of mild-to-moderate hypertension: The efficacy and safety of bisoprolol/HCTZ versus amlodipine, enalapril, and placebo. Cardiovasc Rev Rep. 1996;17:33–45.
   Google Scholar
• Waeber B, Ruilope LM. Amlodipine and valsartan as components of a rational and effective fixed-dose combination. Vasc Health Risk Manag. 2009;5:165–174.
   PubMedGoogle Scholar
• Schrader J, Salvetti A, Calvo C, Akpinar E, Keeling L, Weisskopf M, . The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg. Int J Clin Pract. 2009;63:217–225.
   PubMed Web of Science ®Google Scholar
• Fogari R, Zoppi A, Ferrari I, Mugellini A, Preti P, Derosa G. Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients. Clin Exp Hypertens. 2010;32:245–250.
   PubMed Web of Science ®Google Scholar
• Flack JM, Calhoun DA, Satlin L, Barbier M, Hilkert R, Brunel P. Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in Black patients with stage 2 hypertension: The EX-STAND study. J Hum Hypertens. 2009;23:479–488.
   PubMed Web of Science ®Google Scholar
• Destro M, Luckow A, Samson M, Kandra A, Brunel P. Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: A randomized, double-blind, multicenter study: The EX-EFFects study. J Am Soc Hypertens. 2008;2:294–302.
   PubMed Web of Science ®Google Scholar
• Allemann Y, Fraile B, Lambert M, Barbier M, Ferber P, Izzo JL, Jr. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: The Exforge in Failure After Single THerapy (EX-FAST) study. J Clin Hypertens. 2010;10:185–194.
   Google Scholar
• Devasenapathy N, Singh K, Prabhakaran D. Conduct of clinical trials in developing countries: A perspective. Curr Opin Cardiol. 2009;24:295–300.
   PubMed Web of Science ®Google Scholar
• Stolarz K, Staessen JA, Kuznetsova T, Tikhonoff V, State D, Babeanu S, , on behalf of the European Project on Genes in Hypertension (EPOGH) Investigators. Host and environmental determinants of heart rate and heart rate variability in four European populations. J Hypertens. 2003;21:525–535.
   PubMed Web of Science ®Google Scholar
• Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, . Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113: 1213–1225.
   PubMed Web of Science ®Google Scholar
• Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, . Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther. 2007;29:563–580.
   PubMed Web of Science ®Google Scholar